Brean Capital Downgrades Endocyte To Hold
September 30, 2014 at 08:34 AM EDT
Analysts at Brean Capital downgraded Endocyte (NASDAQ: ECYT) from Buy to Hold. Endocyte shares have dropped 49.27% over the past 52 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.